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Abstract 
This study has investigated damage to the intraperitoneal organs of the rat after systemic (intraperitoneal nd intravenous) administration 
of low doses of 5-aminolevulinic a id (ALA) and illumination with a standard white-light operating-room (o.r.) lamp. The study has been 
done within the framework of a larger study in which the possibility of using ALA for localization of small-volume macroscopically non- 
visible peritoneal metastasis of ovarian tumors is being investigated. Fluorescence diagnostics are done in addition to the standard staging 
and localization procedures, either through alaparoscope orduring laparotomy. Inthese circumstances, fluorescence diagnostics involve some 
risk of photosensitization of critical organs ince a broad-band (o.r.) light source is used during the surgical procedures for illumination of 
the operating area. The drug dose and the time interval between administration of ALA and illumination are varied and normal tissues are 
examined both macroscopically and microscopically for damage. A relationship isdemonstrated between the maximum tolerable dose (MTD) 
of ALA (defined as the dose that does not cause any tissue damage) and the time interval between administration and illumination. The white 
light that is used for illumination of the operating area is sufficient o induce damage to the peritoneal organs at relatively low ALA doses. 
The MDTs for 2, 6 and 16 h intervals are found to be respectively 1,10 and 100 mg kg- 1. The results are similar for both intraperitoneal nd 
intravenous administration. © 1999 Elsevier Science S.A. All rights reserved. 
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1. Introduction 
In the majority of patients with ovarian cancer the diag- 
nosis is established at an advanced stage, when spreading into 
the abdominal cavity has already occurred. The standard stag- 
ing procedure in ovarian cancer without overt spread is done 
by taking multiple blind biopsies at random from peritoneal 
surfaces for microscopical examination. The risk of under- 
staging and subsequent undertreatment wi h this non-directed 
staging procedure is high. 
The problem of possible understaging may be solved by 
using a fluorescence diagnostic technique as a tool for tumor 
localization. In this technique, a fluorescent dye is adminis- 
tered and distributed in the body, resulting in concentration 
gradients which can be used to discriminate normal from 
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tumor tissue. 5-Aminolevulinic acid (ALA)-induced proto- 
porphyrin IX (PplX) is an effective fluorescent agent, which 
has been successfully used for the detection and localization 
of various malignancies [ 1-6]. Hornung et al. [ 1] showed 
that in ovarian cancer ALA may improve detection of super- 
ficial malignant lesions in the abdominal cavity during stag- 
ing and second-look surgery by enabling directed non-blind 
biopsies to be taken. 
ALA is metabolized to PplX, a precursor of heme, which 
will selectively accumulate in tumor tissue. Apart from being 
fluorescent, PplX is also a potent photosensitizer [ 6-21 ]. For 
diagnostic applications the photosensitizing effect is 
unwanted, as it may cause damage to healthy tissue. The 
extent of photosensitization depends on the dosage of ALA 
and the interval between administration ofALA and exposure 
to light, and is highly dependent on the properties of the 
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excitation light source. Fluorescence diagnostics in ovarian 
cancer are carried out during staging laparotomy or laparos- 
copy. Photosensitized tissue will then be exposed to broad 
white light from the operating-room (o.r.) lamp or endo- 
scopic light source. Concern arises as to whether ALA will 
induce damage to critical abdominal organs when they are 
exposed to white light. Hornung et al. [ 1 ] did not report on 
this aspect. 
In the present study we have investigated the macroscopic 
and microscopic damage caused by ALA-induced PplX to 
the abdominal organs of the rat when exposed uring lapa- 
rotomy to a white-light o.r. lamp. Several ALA doses and 
time intervals between ALA administration and light expo- 
sure have been tested and intraperitoneal (i.p.) administra- 
tion of ALA is compared to intravenous (i.v.) administration. 
The aim of our study is to establish arange of doses of ALA 
in combination with different ime intervals that can be used 
safely in staging procedures for ovarian cancer without he 
appearance of harmful photosensitization effects to abdomi- 
nal tissues. 
2. Materials and methods 
2.1. Animals, drug dose and illumination properties 
Adult female Wistar rats (i.p. injections; n= 41 ) or Wag/ 
Rij rats (i.v. injections; n= 22) of approximately 200 g body 
weight were used. The animals received ALA dissolved in 
PBS by an i.p. or i.v. injection. The dose of i.p. ALA varied 
from 1 to 200 mg kg- ;  and the time interval between ALA 
and illumination during laparotomy was 2, 6, 16 or 24 h. For 
the i.v. administration route, drug doses of 1-100 mg kg-  1 
and time intervals between ALA administration a d the pro- 
cedure of 2, 6 or 16 h were used. The experiments were started 
at an i.p. ALA dose of 200 mg kg - 1 and a time of 2 h. These 
conditions were expected to induce evident macroscopic and 
microscopic damage to intra-abdominal organs [7,19,20], 
thus giving an insight into the kind of tissue/cellular damage 
to be expected. The dose of i.p. ALA was subsequently 
decreased (100, 25, 20, 15, 10, 5, 1) until no more signs of 
macroscopic and microscopic damage to healthy tissue were 
found. This dose was considered to be the maximal tolerable 
dose (MTD) of i.p. ALA for a 2 h interval between admin- 
istration and the surgical procedure. Based on the information 
gained from the 2 h interval series, experiments atthe other 
time intervals (6, 16 and 24 h) were performed inthe opposite 
way by starting at a low, probably non-toxic, dose of ALA, 
and increasing this dose until signs of macroscopic and/or 
microscopic damage were found and the MTD could be estab- 
lished. The MTD estimated from the i.p. experiments was 
used as the starting dose for the i.v. dose-finding experiments. 
Two rats were used at each dose level, and the MTD for each 
time interval was confirmed by an additional two rats. Control 
groups were also included, which received no ALA but 
otherwise received the same treatment. 
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Fig. 1. Power spectrum of the Hanau operating-room lamp used. Total output 
100 W m -2 in focal plane. 
All experiments were performed under the same illumi- 
nation conditions using a standard o.r. light source (Original 
Hanau, model 3120). The power spectrum of this lamp, 
depicted in Fig. 1, was measured with a calibrated optical 
multichannel analyzer (Oriel, model 77702, spectrograph 
MS125, calibrated with a model 63355 calibration lamp). 
We calculated the effective power spectrum, defined as the 
product of the (normalized) excitation spectrum of the pho- 
tosensitizer and the power spectrum of the light source [22]. 
The effective power spectrum expresses the effectiveness of
a certain light source for the excitation of a certain photosen- 
sitizer. Using this expression, extrapolation of our results to 
other clinical settings is possible. For future purposes we also 
calculated the effective power spectrum of an endoscope light 
source .  
2.2. Experiments 
Prior to the surgical procedure, the rats that received i.v. 
ALA were anesthesized with Ketamine (90 mg kg-  1 body 
weight, i.m.), Xylazine ( 10 mg kg-  1 body weight, i.m.) and 
Atropine (0.05 mg kg-~ body weight, i.m.). The rats that 
received i.p. ALA were anesthesized by Dormicum (1 mg 
kg-~ body weight i.p.) and Hypnorm (1 mg kg-1 body 
weight i.p.). A midline incision was made from xiphoid to 
symphysis. A surgical retractor was placed in situ, which kept 
the internal abdominal wall folded outside and the intra- 
abdominal organs exposed to the light source. This situation 
was maintained for 2 h with the light source at a working 
distance of 90 cm. Two animals were treated simultaneously. 
The intra-abdominal organs were kept moist during the pro- 
cedure with Ringers solution at 37°C. To maintain body tem- 
perature, an electrical temperature-controlled underlay 
(37°C) was used. During the procedure, liver, small and large 
intestines, peritoneum, skin and bladder were macroscopi- 
cally observed for changes and signs of damage according to 
a standard list. After 2 h the surgical procedure was ended 
and the abdominal skin was sutured. The rats were housed in 
dimmed lighting. Post-operative pain was suppressed with 
Buprenorphin (0.2 ml kg -1 i.m). The rats were sacrificed 
after 72 h. At re-laparotomy the above-mentioned organs 
were observed for macroscopic changes. Samples were taken 
from the liver, small and large intestines, peritoneum, skin 
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and bladder in a standardized way and stored in formalin 
before being sectioned (5 t~m sections) and stained (hema- 
toxylin and eosin) for histological examination. 
3. Results 
3.1. General observations 
In the period between administration fALA and the start 
of surgery, the rats showed no sign of discomfort, although 
the ALA solution was acidic (pH 2.5-5). In one rat, a small 
amount of ALA solution was accidentally injected into sub- 
cuffs and muscle. Necrosis of the muscle was only seen at 16 
h after administration of ALA. I.v. injection in the tail vein 
sometimes resulted in a local hemorrhage. 
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Fig. 2. The combinations of ALA doses (mg kg -~) and time intervals 
(hours) between i.p. administration and treatment at which damage is 
observed (macroscopic damage, during illumination). The organs that were 
judged to be damaged are named in the boxes. 
3.2. Macroscopic observations during the procedure 
In the control group, which received no ALA and/or saline 
solution, no changes to intra-abdominal organs could be 
observed uring and after 2 h of illumination. 
Two animals (200 mg kg- ~ i.p., 2 h interval) died almost 
immediately after the procedure. The macroscopic observa- 
tions during the illumination procedure are summarized in
Fig. 2 for the various combinations ofALA dose (mg kg- 1) 
and time interval (hours) between administration and 
illumination. 
In the exposed (illuminated) part of the liver, we observed 
a change in color during illumination, either reddening or 
blanching and edema, after administration of >_ 5 mg kg-1 
for a time interval of 2 h, >__ 20 mg kg- 1 for a time interval 
of 6 h and > 200 mg kg- l for a time interval of 16 h. In all 
cases, the surface remained intact. A change in appearance 
of the small and large intestines was observed after admin- 
istration of >__ 20 mg/kg ALA for intervals of 2 and 6 h and 
_> 200 mg kg- 1 at 16 h. A swelling of the intestinal wall was 
typically seen, together with focalized hemorrhages on the 
outer surface. The visual appearance of the other intra- 
abdominal organs and the abdominal wall including the skin 
was not macroscopically changed uring the procedure. 
The macroscopic observations during illumination after 
i.v. administration of ALA were comparable with those 
obtained in the i.p. group (see Fig. 3). 
3.3. Macroscopic observations after 72 h 
In the control group, which received no ALA and/or saline 
solution, no changes to intra-abdominal organs were 
observed. During the three days after the procedure, the ani- 
mals showed no change in behavior and weight loss was 
limited to a maximum of 15%, which was not different from 
the weight loss seen after surgery alone. 
The macroscopic observations after 72 h are summarized 
in Figs. 4 and 5. Findings were comparable with those found 
during the surgical procedure. The discoloration of the liver 
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Fig. 3. The combinations of ALA doses (mg kg 1) and time intervals 
(hours) between i.v. administration and treatment at which damage is 
observed (macroscopic damage, during illumination). The organs that were 
judged to be damaged are named in the boxes. 
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Fig. 4. The combinations of ALA doses (mg kg - I )  and time intervals 
(hours) between i.p. administration and treatment at which damage is 
observed (macroscopic damage, 72 h after illumination). The organs that 
were judged to be damaged are named in the boxes. 
observed uring the illumination was in most cases still 
noticeable after 72 h. Additionally, in these cases a white line 
was observed, which delineated the illuminated area. The 
swelling of the intestines had disappeared in all cases. In a 
few cases a faint reddish discoloration was still present. No 
macroscopic changes to the other intra-abdominal organs 
could be observed. Findings were similar for both i.v.- and 
i.p.-treated rats. 
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Fig. 5. The combinations of ALA doses (mg kg -~) and time intervals 
(hours) between i.v. administration a d treatment a which damage is
observed (macroscopic damage, 72 h after illumination). The organs that 
were judged to be damaged are named in the boxes. 
Fig. 6. Small-intestine wall (dose i.p. 25 mg kg- ~, interval 2h). A: on the 
illuminated side the mucosa has disappeared, while at the dark side (B, 
shielded from the light by feces) the mucosa isstill intact. The other layers 
remain intact. 
3.4. Microscopic observations 
Microscopic damage was limited to the liver and the intes- 
tine (wall). A typical example of the changes due to white- 
light illumination of the small intestine is shown in Fig. 6 
(i.p., 25 mg kg-  1, 2 h interval). The outer layers, muscularis 
and submucosa, were intact, while the mucosa on the side of 
the bowel exposed to the light source (A) has completely 
disappeared. The opposite mucosa, shielded by feces from 
the light source, remained intact. Fig. 7 shows the damage to 
the liver of the same rat. A clearly demarcated area with cell 
damage is seen at the illuminated side. The thickness of this 
damaged layer is approximately 0.4 mm. The damage to both 
the liver and intestines was focal. In one rat ( i.v., 25 mg kg - 1, 
6 h interval) a necrotic superficial vessel wall was observed 
in the liver. We have not seen any abnormalities in other 
abdominal organs. In the control group no damage was seen 
to illuminated organs. 
3.5. Maximum tolerable dose (MTD) 
To obtain the MTD (no sign of macroscopic or micro- 
scopic damage) for the tandem dose of ALA and time inter- 
val, we combined the results from Figs. 2 and 3 (macroscopic 
observations during the procedure), Figs. 4 and 5 (macro- 
scopic observations after 72 h) and the microscopic obser- 
vations. For the 2 h interval the MTD was established at 1 
mg kg-  1; for the 6 h interval the MTD was established at 10 
mg kg-  1 and for the 16 h interval the MTD was established 
at 100 mg kg-  1. 
3.6. Effective power spectrum 
The effective power spectrum of the o.r. light used in these 
studies and the relative excitation spectrum of PpIX are 
depicted in Fig. 8. For comparison, Fig. 9 shows the effective 
power spectrum of an endoscope white-light source ( 100 W 
xenon) with the absolute power spectrum measured 5 cm 
from the distal end. 
4. D iscuss ion  
Photodetection using ALA-induced PpIX may be an attrac- 
tive new diagnostic development in ovarian cancer diagnostic 
strategies. Photodetection can be added to current staging 
procedures like laparoscopy or laparotomy, enabling the 
localization of macroscopically non-visible metastases. How- 
ever, fluorescent diagnostics carry a risk of damage to tissue 
due to the photosensitization properties of PpIX. This risk is 
determined by the illumination properties (power and wave- 
length) of the light source, the dose of photosensitizer, the 
interval before illumination and the type of tissue/organ. 
During the photodetection-assisted staging procedures, 
which can last several hours, the abdominal cavity will be 
exposed not only to blue light from the excitation source but 
also to intense white light from the endoscopic light sources 
or o.r. lamps. In order to minimize the risk of phototoxic 
Fig. 7. Zone of ceil damage atthe illuminated side of the liver (dose i.p. 25 mg kg- J, interval 2h). 
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Fig. 8. The relative absorption spectrum of protoporphyrin IX (dashed line) 
that we used to calculate the effective power spectrum of the operating-room 
lamp (full line). 
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Fig. 9. The effective power spectrum of a white-light endoscope (xenon). 
damage in future photodetection-assisted aging procedures, 
we have established safe ALA dose/time intervals when 
using white-light sources in a rat model. 
Safe doses (MTDs) were established at1, 10 and 100 mg 
kg-  ] for intervals of 2, 6 and 16 h, respectively, for both i.v. 
and i.p. routes of administration. As can be expected, the 
shorter the time interval, the lower the MTD for ALA. Low 
dosages of ALA may not be very useful in photodetection. 
The success of photodetection diagnostics i based on differ- 
ences in concentrations of photosensitizer between ormal 
and tumor tissue and low ALA doses may not give enough 
contrast. In that case, a higher ALA dose at a longer time 
interval should be used for clinical applications. Recently 
Hornung published on photodetection diagnostics of carci- 
nomatosis in the (rat) abdominal cavity using ALA in com- 
bination with a blue excitation light source [1 ]. He observed 
the best contrast between tumor fluorescence and normal 
(peritoneum) fluorescence in the abdominal cavity 3 h after 
administration of 100 mg kg-1 ALA. The combination of 
this relatively high drug dose and short time interval 
(between administration of ALA and illumination) would 
result in considerable tissue damage on exposure to the illu- 
mination conditions that we used in our experiments. 
When evaluating the safety of photodetection diagnostics, 
both the severity and the (it)reversibility of any induced 
damage of healthy tissue have to be taken into account. In 
this study we considered any macroscopic or microscopic 
change in organs as phototoxic damage. Phototoxic damage 
appeared to be restricted to the liver and small bowel. The 
observed amage would probably have little impact on the 
functionality of the organs involved, particularly in the liver, 
where damage was limited to a superficial layer (0.4 mm). 
Due to the structure and size of the liver, this would have few 
functional consequences. Damage to the intestinal wall was 
limited to the mucosa, whereas the muscular wall remained 
intact. Our study was limited to an evaluation of damage at 
72 h after illumination. Longer follow-up would, presumably, 
indicate regeneration f the damaged mucosa from unaffected 
areas. The chance of severe complications, like bowel per- 
foration, therefore seems to be limited. Nevertheless, our 
results in rats indicate that caution should be taken when 
applying photodetection diagnostics using intense light 
sources. So far no clinical studies mention any phototoxic 
damage as a possible side effect of photodetection diagnostic 
procedures, even if white-light sources are used. The discrep- 
ancy between our rat data and these clinical observations 
could be related to the larger mass of human organs, with any 
damage being restricted to superficial layers without func- 
tional consequences. However, this has not been systemati- 
cally evaluated and the impression remains that possible 
damage might be overlooked inclinical studies. Our intention 
was not to give absolute safe doses for humans, but rather to 
demonstrate he potential for toxic side effects during pho- 
todetection procedures with high doses (and short intervals) 
of ALA. The study also indicates conservative safe doses 
where no damage is to be expected. 
5. Suggestions of precautions 
To avoid phototoxicity in normal tissues during photo- 
detection procedures, the following should be considered: 
phototoxicity is determined by the light-source properties, 
the dose of ALA and the interval between application and 
surgical procedure [ 22,23 ]. In photodetection diagnostics via 
laparoscopy and laparotomy the use of white light cannot be 
avoided. Modification of the light source by using filters for 
blocking the blue part of the light source spectrum isnot very 
effective, as only a small influence on the effective power is 
obtained. In contrast o a common misunderstanding, the 
white-light source of an endoscope is about 20 times more 
effective in causing damage to sensitized tissue than an o.r. 
lamp (as demonstrated in Fig. 9). This leaves the time of 
exposure and the drug dose as potential variables in dimin- 
ishing damage. In a clinical setting a time interval has to be 
used where the ALA dose is below the MTD but sufficient 
to enable discrimination between ormal and tumor tissue. 
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